REGULATION OF SYNAPSE DENSITY BY 5-HT2A RECEPTOR AGONIST AND ANTAGONIST IN THE SPINAL-CORD OF CHICKEN-EMBRYO

被引：36
|
作者：
NIITSU, Y
HAMADA, S
HAMAGUCHI, K
MIKUNI, M
OKADO, N
机构：
[1] UNIV TSUKUBA,INST BASIC MED SCI,DEPT ANAT,NEUROBIOL LAB,TSUKUBA,IBARAKI 305,JAPAN
[2] GUNMA UNIV,SCH MED,DEPT PSYCHIAT,MAEBASHI,GUMMA 371,JAPAN
来源：
NEUROSCIENCE LETTERS | 1995年 / 195卷 / 03期
关键词：
SYNAPSE; PLASTICITY; SEROTONIN; RECEPTOR; SPINAL CORD;
D O I：
10.1016/0304-3940(95)11805-7
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Identification of mechanisms that regulate the number of synapses in the brain has been a key issue for understanding the mechanism of plasticity. Here, we report that the density of synapses can be changed using an antagonist and/or an agonist of serotonin (5-HT) type 2A receptors in the chicken spinal cord. Because of the widespread distribution pattern of 5-HT fibers and 5-HT2A receptors in the central nervous system, 5-HT is thought to play a role in the formation and maintenance of synapses that are involved in normal brain function and mechanism of plasticity.
引用
收藏
页码：159 / 162
页数：4
相关论文
共 50 条
  • [21] Effects of psilocybin, the 5-HT2A receptor agonist TCB-2, and the 5-HT2A receptor antagonist M100907 on visual attention in male mice in the continuous performance test
    Rahbarnia, Arya
    Li, Zhaoxia
    Fletcher, Paul J.
    PSYCHOPHARMACOLOGY, 2023,
  • [22] Agonist-selective internalization of the human 5-HT2A receptor
    Buchborn, T.
    Kahl, E.
    Hoellt, V
    Koch, T.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2012, 385 : 17 - 17
  • [23] Investigating functional selectivity in rat 5-HT2A receptor agonist- and antagonist-mediated trafficking
    Raote, I
    Panicker, M. M.
    JOURNAL OF NEUROCHEMISTRY, 2008, 106 : 48 - 48
  • [24] Ergovaline acts as both an agonist and antagonist on serotonin receptor 5-HT2A in bovine ruminal and mesenteric vasculature
    Trotta, R.
    Harmon, D.
    Klotz, J.
    JOURNAL OF ANIMAL SCIENCE, 2018, 96 : 46 - 47
  • [25] Bromocriptine acts as a partial agonist at the human 5-HT2A receptor
    Mitchell, AL
    Phipps, SL
    Grahame-Smith, DG
    Elliott, JM
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 : U34 - U34
  • [26] SDZ NVI 085, an alpha(1A)-adrenoceptor agonist with 5-HT2A receptor antagonist properties
    Lachnit, WG
    Ford, APDW
    Clarke, DE
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 297 (1-2) : 83 - 86
  • [27] Desensitisation-induced changes in the binding of agonist and antagonist radioligands to the transfected human 5-HT2A receptor
    Briddon, SJ
    Leslie, RA
    Elliott, JM
    BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 : P292 - P292
  • [28] Progress Towards the Synthesis of a Photoisomerizable Antagonist of the 5-HT2A Receptor
    Robert, Noelle
    Streu, Craig
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2023, 299 (03) : S111 - S111
  • [29] Effect of 5-HT2a Receptor Agonist DOI on Epileptiform Activity
    Taskiran, Mehmet
    Tasdemir, Abdulkadir
    Ayyildiz, Mustafa
    Agar, Erdal
    Ayyildiz, Nusret
    ACTA PHYSIOLOGICA, 2015, 215 : 96 - 96
  • [30] Evidence for inverse agonist activity at the 5-HT2A receptor in vivo
    Romano, AG
    Quinn, JL
    Liu, RJ
    Dave, KD
    Schwab, DL
    Alexander, GM
    Aloyo, VJ
    Harvey, JA
    FASEB JOURNAL, 2004, 18 (05): : A965 - A965
12345